日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oncolytic HSV-IL27 expression improves CD8 T cell function and therapeutic activity in syngeneic glioma models

溶瘤性 HSV-IL27 表达可改善同源胶质瘤模型中 CD8 T 细胞的功能和治疗活性

Martin, Alexia K; Hedberg, Jack; Hernandez-Aguirre, Ilse; Saini, Uksha; Kim, Doyeon; Kim, Yeaseul; Dhital, Ravi; Cassady, Kevin A

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma

采用抗ROR1 CAR NK细胞和分泌IL-21的溶瘤病毒联合免疫疗法治疗神经母细胞瘤

Chu, Yaya; Tian, Meijuan; Saini, Uksha; Ayala-Cuesta, Jessica; Klose, Kayleigh; Mendelowitz, Alyssa S; Foley, Keira; Ozkaynak, Mehmet F; Luo, Wen; Cripe, Timothy P; Lee, Dean A; Cassady, Kevin A; Cairo, Mitchell S

Pharmacological characterization and preclinical evaluation of 11h: a novel, brain-penetrant PDE4 inhibitor for neurological disorders

11h 的药理学特性及临床前评价:一种新型的、可穿透血脑屏障的 PDE4 抑制剂,用于治疗神经系统疾病

Lackovic, Jacob; Dey, Sougata; Ward, Sara Jane; Greig, Nigel H; Tweedie, David; Beiranvand, Nassim; Saini, Uksha; Chatterjee, Dev; Varadhachary, Atul

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy.

IL-12转基因表达增强可改善溶瘤病毒免疫疗法

Kim Yeaseul, Saini Uksha, Kim Doyeon, Hernandez-Aguirre Ilse, Hedberg Jack, Martin Alexia, Mo Xiaokui, Cripe Timothy P, Markert James, Cassady Kevin A, Dhital Ravi

Primary murine high-grade glioma cells derived from RCAS/tv-a diffuse glioma model reprogram naive T cells into immunosuppressive regulatory T lymphocytes

源自 RCAS/tv 的原代小鼠高级别胶质瘤细胞(一种弥漫性胶质瘤模型)可将幼稚 T 细胞重编程为免疫抑制性调节性 T 淋巴细胞。

Canella, Alessandro; Artomov, Mykyta; Ukhatov, Aleksandr; Rajendran, Sakthi; Perez, Phillip; Saini, Uksha; Hedberg, Jack; Cassady, Kevin; Rajappa, Prajwal

Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

更正:利用溶瘤病毒靶向治疗卵巢透明细胞癌中TMEM205介导的耐药性

Saini, Uksha; Smith, Brentley Q; Dorayappan, Kalpana Deepa Priya; Yoo, Ji Young; Maxwell, G Larry; Kaur, Balveen; Konishi, Ikuo; O'Malley, David; Cohn, David E; Selvendiran, Karuppaiyah

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

利用溶瘤病毒靶向治疗卵巢透明细胞癌中TMEM205介导的耐药性

Saini, Uksha; Smith, Brentley Q; Dorayappan, Kalpana Deepa Priya; Yoo, Ji Young; Maxwell, G Larry; Kaur, Balveen; Konishi, Ikuo; O'Malley, David; Cohn, David E; Selvendiran, Karuppaiyah

Eliciting an immune-mediated antitumor response through oncolytic herpes simplex virus-based shared antigen expression in tumors resistant to viroimmunotherapy

通过溶瘤性单纯疱疹病毒在对病毒免疫疗法耐药的肿瘤中表达共享抗原,诱导免疫介导的抗肿瘤反应

Ghonime, Mohammed G; Saini, Uksha; Kelly, Michael C; Roth, Justin C; Wang, Pin-Yi; Chen, Chun-Yu; Miller, Katherine; Hernandez-Aguirre, Ilse; Kim, Yeaseul; Mo, Xiaokui; Stanek, Joseph R; Cripe, Tim; Mardis, Elaine; Cassady, Kevin A

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

溶瘤 HSV 疗法调节囊泡运输诱导顺铂敏感性和抗肿瘤免疫

Bangxing Hong, Valerie Chapa, Uksha Saini, Puneet Modgil, David E Cohn, Guangan He, Zahid H Siddik, Anil K Sood, Yuanqing Yan, Karuppaiyah Selvendiran, Guangsheng Pei, Zhongming Zhao, Ji Young Yoo, Balveen Kaur

STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube

STAT3/PIAS3 水平是输卵管高级别浆液性癌发展的“早期特征”基因

Uksha Saini, Adrian A Suarez, Shan Naidu, John J Wallbillich, Kristin Bixel, Ross A Wanner, Jason Bice, Raleigh D Kladney, Jenny Lester, Beth Y Karlan, Paul J Goodfellow, David E Cohn, Karuppaiyah Selvendiran